Maravai Lifesciences Holdings Inc (NASDAQ:MRVI) — Market Cap & Net Worth
Market Cap & Net Worth: Maravai Lifesciences Holdings Inc (MRVI)
Maravai Lifesciences Holdings Inc (NASDAQ:MRVI) has a market capitalization of $1.03 Billion ($1.03 Billion) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8776 globally and #2519 in its home market, demonstrating a -6.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maravai Lifesciences Holdings Inc's stock price $6.88 by its total outstanding shares 148989545 (148.99 Million). Also see MRVI total assets for a full breakdown of the balance sheet.
Maravai Lifesciences Holdings Inc Market Cap History: 2020 to 2026
Maravai Lifesciences Holdings Inc's market capitalization history from 2020 to 2026. Data shows change from $4.18 Billion to $1.03 Billion (-22.28% CAGR). Also see how efficiently does Maravai Lifesciences Holdings Inc generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
Maravai Lifesciences Holdings Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.04% | #254 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.00% | #943 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.88 Trillion | 0.05% | #147 of 263 |
Weight: Maravai Lifesciences Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Maravai Lifesciences Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maravai Lifesciences Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Maravai Lifesciences Holdings Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.61x
Maravai Lifesciences Holdings Inc's market cap is 2.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $4.18 Billion | $284.10 Million | $76.89 Million | 14.71x | 54.35x |
| 2021 | $6.24 Billion | $799.24 Million | $182.04 Million | 7.81x | 34.29x |
| 2022 | $2.13 Billion | $883.00 Million | $220.21 Million | 2.41x | 9.68x |
| 2023 | $975.88 Million | $288.94 Million | -$119.03 Million | 3.38x | N/A |
| 2024 | $811.99 Million | $259.19 Million | -$144.85 Million | 3.13x | N/A |
| 2025 | $484.22 Million | $185.74 Million | -$130.77 Million | 2.61x | N/A |
Competitor Companies of MRVI by Market Capitalization
Companies near Maravai Lifesciences Holdings Inc in the global market cap rankings as of September 17, 2026. Review MRVI tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Maravai Lifesciences Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Maravai Lifesciences Holdings Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Maravai Lifesciences Holdings Inc's market cap moved from $4.18 Billion to $ 1.03 Billion, with a yearly change of -22.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.03 Billion | +111.69% |
| 2025 | $484.22 Million | -40.37% |
| 2024 | $811.99 Million | -16.79% |
| 2023 | $975.88 Million | -54.23% |
| 2022 | $2.13 Billion | -65.85% |
| 2021 | $6.24 Billion | +49.38% |
| 2020 | $4.18 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Maravai Lifesciences Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.03 Billion USD |
| MoneyControl | $1.03 Billion USD |
| MarketWatch | $1.03 Billion USD |
| marketcap.company | $1.03 Billion USD |
| Reuters | $1.03 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Maravai Lifesciences Holdings Inc
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products fo… Read more